Skip to main content
logo
Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
1.870
+0.010 (0.54%)
Aug 7, 2026, 1:58 PM EDT - Market open

Annovis Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
809471197110142
Market Cap Growth
50.09%32.30%-63.84%79.42%-23.01%174.06%
Enterprise Value
65.3374.5860.58190.9781.2696.72
Last Close Price
1.873.465.0318.7013.4317.58

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
16.985.587.64-25.383.873.20
P/TBV Ratio
13.884.226.61-3.873.01

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-4.55-1.16-1.130.74-1.00-1.03
Net Debt / EBITDA Ratio
0.340.660.400.131.113.14
Net Debt / FCF Ratio
0.540.760.480.141.645.00
Quick Ratio
1.115.372.721.343.6930.33
Current Ratio
1.275.803.592.394.6830.54
Return on Equity (ROE)
-409.70%-220.61%-3159.09%-546.40%-69.57%-55.68%
Return on Assets (ROA)
-221.97%-169.65%-221.22%-194.83%-62.20%-53.72%
Return on Invested Capital (ROIC)
---30607.50%-51635.60%--
Return on Capital Employed (ROCE)
-396.42%-216.04%-334.23%-262.96%-70.07%-55.87%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-66.78%-67.97%-35.60%-10.55%-7.03%-20.88%
Total Shareholder Return
-66.78%-67.97%-35.60%-10.55%-7.03%-20.88%
SEC Filings: 10-K · 10-Q